Endoscopic equipment and techniques are an evolving field. Updates are necessary to keep up with the growth of GI practice. Cleveland Clinic Florida has a strong GI faculty with subspecialty training and interests who, through teaching and research, are at the forefront of gastroenterology and endoscopy.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Nurses, technicians and additional support staff are important members of the team in the GI suite. Education and training opportunities are limited and we are pleased to present a course which covers usual clinical scenarios, followed by hands‐on sessions where nurses and ancillary staff have a chance to handle equipment. We look forward to filling this unmet need for education in the region.
Gastroenterology nurses, technicians and other related healthcare professionals
Cleveland Clinic Florida, Jagelman Conference Center
Weston, Florida
For more information, visit Cleveland Clinic Florida ConsultQD. Subscribe to the Florida Physician Newsletter.
Additionally, follow us on X (formerly Twitter), Facebook, and LinkedIn.
Advertisement
Advertisement
Nonthermal technique reduces bleeding and perforation risk
Standardizing a minimally invasive approach for Barrett’s Esophagus and Esophageal Cancer
PSMA-targeted therapy for metastatic prostate cancer now offered at Cleveland Clinic Weston Hospital
Nationally recognized urologic oncologist offers vision for growth, innovation, and excellence
Noninvasive modality gains ground in United States for patients with early-to-moderate disease
Cleveland Clinic Weston Hospital’s collaborative model elevates care for complex lung diseases
Interventional pulmonologists at Cleveland Clinic Indian River Hospital use robotic technology to reach small peripheral lung nodules
Trained in the use of multiple focal therapies for prostate cancer, Dr. Jamil Syed recommends HIFU for certain patients with intermediate-risk prostate cancer, especially individuals with small, well-defined tumors localized to the lateral and posterior regions of the gland.